David A. Siegel Nano Vibronix, Inc. Transaction History

Two Sigma Advisers, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$0.7 - $3.37 $14,349 - $69,085	-20,500 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$0.79 - $1.15 $4,345 - $6,324	5,500 Added 36.67%	20,500 $17,000
Q1 2021 May 17, 2021	BUY	$0.83 - $1.51 $12,450 - $22,650	15,000 New	15,000 $15,000

Ticker NAOV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,997,800
Market Cap $16.2M
Description
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary ca...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.